These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35891225)

  • 41. Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study.
    El-Sokkary RH; El Seifi OS; Hassan HM; Mortada EM; Hashem MK; Gadelrab MRMA; Tash RME
    BMC Infect Dis; 2021 Aug; 21(1):762. PubMed ID: 34353279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series.
    Tan KYK; Soh ASE; Ong BWL; Chen MI; Griva K
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
    Rababa'h AM; Abedalqader NN; Ababneh M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes of Healthcare Workers in Israel towards the Fourth Dose of COVID-19 Vaccine.
    Ramot S; Tal O
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the acceptability of COVID-19 vaccine and its booster dose.
    Mubarak S; A'aqoulah A; AlGhawrie H; Albalas S; Innab N
    Immun Inflamm Dis; 2023 Sep; 11(9):e950. PubMed ID: 37773710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 vaccination willingness among people with multiple sclerosis.
    Xiang XM; Hollen C; Yang Q; Brumbach BH; Spain RI; Wooliscroft L
    Mult Scler J Exp Transl Clin; 2021; 7(2):20552173211017159. PubMed ID: 34104472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of the Third (Booster) Dose of COVID-19 Vaccine Intention among the Healthcare Workers in Saudi Arabia: An Online Cross-Sectional Survey.
    Alobaidi S; Hashim A
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou, China.
    Lin XQ; Li AL; Zhang MX; Lv L; Chen Y; Chen HD; Tung TH; Zhu JS
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of Seasonal Influenza Vaccination Willingness among High-Risk Populations Three Years after the Onset of the COVID-19 Pandemic.
    Katsiroumpa A; Sourtzi P; Kaitelidou D; Siskou O; Konstantakopoulou O; Galanis P
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study.
    Yadete T; Batra K; Netski DM; Antonio S; Patros MJ; Bester JC
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.
    Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L
    BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population.
    Ayyalasomayajula S; Dhawan A; Karattuthodi MS; Thorakkattil SA; Abdulsalim S; Elnaem MH; Sridhar S; Unnikrishnan MK
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Psychological Experience of COVID-19 Vaccination and Its Impact on the Willingness to Receive Booster Vaccines among the Chinese Population: Evidence from a National Cross-Sectional Study.
    Miao Y; Li Y; Zhang W; Wu J; Gu J; Wang M; Wei W; Ye B; Miao C; Tarimo CS; Dong W
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Willingness to Receive a COVID-19 Vaccine and Associated Factors among Older Adults: A Cross-Sectional Survey in Shanghai, China.
    Wu L; Wang X; Li R; Huang Z; Guo X; Liu J; Yan H; Sun X
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine.
    Cordina M; Lauri MA; Lauri J
    Pharm Pract (Granada); 2021; 19(1):2317. PubMed ID: 33828623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intentions of Patients with Hypertension to Receive a Booster Dose of the COVID-19 Vaccine: A Cross-Sectional Survey in Taizhou, China.
    Ying CQ; Lin XQ; Lv L; Chen Y; Jiang JJ; Zhang Y; Tung TH; Zhu JS
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China.
    Shao H; Lin XQ; Chen Y; Lv L; Ying CQ; Tung TH; Zhu JS
    Hum Vaccin Immunother; 2023 Dec; 19(1):2158012. PubMed ID: 36606519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community.
    Govere-Hwenje S; Jarolimova J; Yan J; Khumalo A; Zondi G; Ngcobo M; Wara NJ; Zionts D; Bogart LM; Parker RA; Bassett IV
    BMC Public Health; 2022 Jun; 22(1):1239. PubMed ID: 35733209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study.
    Zoumpoulis G; Deligiorgi P; Lamprinos D; Georgakopoulos P; Oikonomou E; Siasos G; Rachiotis G; Damaskos C; Papagiannis D; Papavassiliou KA; Patoulis G; Patsourakos F; Benetou V; Riza E; Orfanos P; Lagiou P; Marinos G
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.
    Digregorio M; Van Ngoc P; Delogne S; Meyers E; Deschepper E; Dardenne N; Duysburgh E; De Rop L; De Burghgraeve T; Coen A; De Clercq N; De Sutter A; Verbakel JY; Cools P; Heytens S; Buret L; Scholtes B
    Vaccine X; 2024 Jan; 16():100453. PubMed ID: 38361529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.